These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 15925326

  • 1. Regulation of the cell cycle in response to inhibition of mitochondrial generated energy.
    Gemin A, Sweet S, Preston TJ, Singh G.
    Biochem Biophys Res Commun; 2005 Jul 15; 332(4):1122-32. PubMed ID: 15925326
    [Abstract] [Full Text] [Related]

  • 2. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 3. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 4. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 5. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 6. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 7. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C, Chattopadhyay A, Parkhurst C, Yang E.
    Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213
    [Abstract] [Full Text] [Related]

  • 8. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 07; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 10. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL, McLean TI, Bachenheimer SL.
    Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629
    [Abstract] [Full Text] [Related]

  • 11. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 12. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA.
    Oncogene; 1998 Aug 20; 17(7):867-76. PubMed ID: 9780003
    [Abstract] [Full Text] [Related]

  • 13. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR.
    Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430
    [Abstract] [Full Text] [Related]

  • 14. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts.
    Dietrich C, Wallenfang K, Oesch F, Wieser R.
    Oncogene; 1997 Nov 27; 15(22):2743-7. PubMed ID: 9401001
    [Abstract] [Full Text] [Related]

  • 15. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J, Serna C, Garriga J, Graña X, Mazo A.
    Cell Death Differ; 2004 Oct 27; 11(10):1055-65. PubMed ID: 15309028
    [Abstract] [Full Text] [Related]

  • 16. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats.
    Jiang W, Zhu Z, Thompson HJ.
    Cancer Res; 2003 Mar 15; 63(6):1228-34. PubMed ID: 12649181
    [Abstract] [Full Text] [Related]

  • 17. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
    Kilbey A, Stephens V, Bartholomew C.
    Cell Growth Differ; 1999 Sep 15; 10(9):601-10. PubMed ID: 10511310
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 19. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 01; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F, Djakiew D.
    Mol Carcinog; 2003 Mar 01; 36(3):153-60. PubMed ID: 12619038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.